AVTXBiotechnology / Biotechnology
Avalo Therapeutics Inc
30-Day Price
Key Metrics
Latest Close
$13.42
Market Cap
$263M
Shares Outstanding
18,130,000
P/B Ratio
0.58
ROE
-2641.00%
ROA
-2331.00%
Gross Margin
24218.00%
Operating Margin
-593469.00%
Net Margin
-278957.00%
Debt / Equity
0.02
Current Ratio
19.96
Want the full picture?
Sign up free for full analysis, strategy backtesting with credibility scoring, portfolio management, and more.
Start Free